NCT06855433View on ClinicalTrials.gov

Colchicine to Reduce Your SympToms and Lower Levels of Inflammation, Zeroing in on Effective CPPD Disease Treatment

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

April 1, 2029

Study Completion Date

May 1, 2029

Conditions
CPPD - Calcium Pyrophosphate Deposition Disease
Interventions
DRUG

Colchicine Pill

Colchicine 0.6mg tab, overencapsulated to match placebo capsule, taken by mouth once daily

DRUG

Placebo

Placebo capsule, taken by mouth once daily

All Listed Sponsors
collaborator

Rheumatology Research Foundation

OTHER

lead

Brigham and Women's Hospital

OTHER